PEAK6 Investments’s Medicines Co MDCO Stock Holding History

PEAK6 Investments’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-158,500	Closed	-$13.5M	–	4764
2019 Q4	$13.5M	Sell	158,500 -31,000	-16%	-$2.07M	0.07%	295
2019 Q3	$9.47M	Buy	+189,500	New	+$7.56M	0.06%	382

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

PEAK6 Investments's MDCO Position: Q1 2020 in Review

PEAK6 Investments sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 12,816 shares — an estimated $1.09M sold.

PEAK6 Investments first reported a position in MDCO in Q3 2019 and held it in 2 quarters. The position peaked at $1.09M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

PEAK6 Investments reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
PEAK6 Investments sold 12,816 Medicines Co shares in Q1 2020, an estimated $1.09M.
PEAK6 Investments first reported a position in Medicines Co in Q3 2019 and held it in 2 quarters.
PEAK6 Investments's Medicines Co position peaked at $1.09M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on PEAK6 Investments's 13F filing for Q1 2020, filed 14 May 2020.